Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Endocrine Pathology
Published in: Endocrine Pathology 2/2006

01-06-2006 | European Congress for Pathology Symposium: Criteria for Malignancy in Endocrine Tumors

New developments in the detection of the clinical behavior of pheochromocytomas and paragangliomas

Authors: Dr. Ronald R. de Krijger, MD, PhD, Francien H. van Nederveen, MD, Esther Korpershoek, BSc, Winand N. M. Dinjens, PhD

Published in: Endocrine Pathology | Issue 2/2006

Login to get access
Metadata
Title
New developments in the detection of the clinical behavior of pheochromocytomas and paragangliomas
Authors
Dr. Ronald R. de Krijger, MD, PhD
Francien H. van Nederveen, MD
Esther Korpershoek, BSc
Winand N. M. Dinjens, PhD
Publication date
01-06-2006
Publisher
Humana Press
Published in
Endocrine Pathology / Issue 2/2006
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1385/EP:17:2:137

Other articles of this Issue 2/2006

Endocrine Pathology 2/2006 Go to the issue

Review

Recent insights into the molecular pathogenesis of pheochromocytoma and paraganglioma

Case Report

Presence of the BRAF V600E point mutation in morphologically benign appearing thyroid inclusions of cervical lymph nodes

Clinical Research

Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series

European Congress for Pathology Symposium: Criteria for Malignancy in Endocrine Tumors

Diagnostic criteria in well-differentiated thyroid carcinomas

Clinical Research

PTTG overexpression is correlated with angiogenesis in human pituitary adenomas

Clinical Research

Diversity of ACTH-immunoreactive cells in the human adenohypophysis: An immunohistochemical study with special reference to cluster formation and follicular cell association
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits